Defining the optimal dose of radiation after incomplete resection of central neurocytomas

被引:43
作者
Rades, D
Schild, SE
Ikezaki, K
Fehlauer, F
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Radiat Oncol, D-20246 Hamburg, Germany
[2] Mayo Clin Scottsdale, Dept Radiat Oncol, Scottsdale, AZ USA
[3] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 55卷 / 02期
关键词
central neurocytoma; incomplete tumor resection; total radiation dose;
D O I
10.1016/S0360-3016(02)03918-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Central neurocytomas are uncommon benign central nervous system tumors. There is uncertainty regarding the most appropriate radiation dose after incomplete resection. This analysis was performed to determine the optimal dose. Methods and Materials: All cases reported since 1982 were reviewed for age, gender, resection status, total dose, dose per fraction, local control, and overall survival. Additional data were obtained from the authors. The inclusion criteria were incomplete resection, postoperative irradiation, complete data, and 12 months' minimal follow-up. Two groups were formed according to the equivalent dose in 2-Gy fractions (EQD2): group A (40.0-53.6 Gy) and group B (54.0-62.2 Gy). Local control and survival were compared using Kaplan-Meier analysis and the log-rank test. Results: Eighty-nine patients (group A 42, group B 47) met the inclusion criteria. At 5 years, the local control rate was 98% for group B vs. 69% for group A. At 10 years, it was 89% vs. 65% (P = 0.0066). The 5- and 10-year survival rate was 98% for group B vs. 88% for group A (p = 0.1). Conclusions: Our data suggest that a EQD2 greater than or equal to54 Gy significantly improves local control in patients with subtotally resected neurocytomas. Although the difference in survival was not significant, a trend toward better survival was noted after a EQD2 of greater than or equal to54 Gy. (C) 2003 Elsevier Science Inc.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 56 条
[1]   CENTRAL NEUROCYTOMA - REPORT OF 2 CASES AND LITERATURE-REVIEW [J].
AGRANOVICH, AL ;
ANG, LC ;
FRYER, CJH .
JOURNAL OF NEURO-ONCOLOGY, 1993, 16 (01) :47-53
[2]   Radiosurgery for the treatment of recurrent central neurocytomas [J].
Anderson, RC ;
Elder, LB ;
Parsa, AT ;
Issacson, SR ;
Sisti, MB .
NEUROSURGERY, 2001, 48 (06) :1231-1237
[3]  
[Anonymous], 1997, BASIC CLIN RADIOBIOL
[4]   DOSE FRACTIONATION, DOSE-RATE AND ISO-EFFECT RELATIONSHIPS FOR NORMAL TISSUE RESPONSES [J].
BARENDSEN, GW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11) :1981-1997
[5]   Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report [J].
Bertalanffy, A ;
Roessler, E ;
Dietrich, W ;
Aichholzer, M ;
Prayer, D ;
Ertl, A ;
Kitz, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (04) :489-493
[6]  
Brandes AA, 2000, CANCER, V88, P169, DOI 10.1002/(SICI)1097-0142(20000101)88:1<169::AID-CNCR23>3.0.CO
[7]  
2-7
[8]   Extraventricular neurocytomas - Pathologic features and clinical outcome [J].
Brat, DJ ;
Scheithauer, BW ;
Eberhart, CG ;
Burger, PC .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) :1252-1260
[9]   Management of neurocytomas - Case report and review of the literature [J].
Brown, DM ;
Karlovits, S ;
Lee, LH ;
Kim, K ;
Rothfus, WE ;
Brown, HG .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03) :272-278
[10]   CENTRAL NEUROCYTOMA - A CLINICOPATHOLOGICAL STUDY OF 5 CASES [J].
CASADEI, GP ;
ARRIGONI, GL ;
VERSARI, P ;
GAMBACORTA, M ;
GIANGASPERO, F .
TUMORI, 1991, 77 (04) :323-327